Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial

BACKGROUND: CirCe01 trial aimed to assess the clinical utility of circulating tumour cell (CTC)-based monitoring in metastatic breast cancer (MBC) patients beyond the third line of chemotherapy (LC). METHODS: CirCe01 was a prospective, multicentre, randomised trial (NCT01349842) that included patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabel, Luc, Berger, Frédérique, Cottu, Paul, Loirat, Delphine, Rampanou, Aurore, Brain, Etienne, Cyrille, Stacy, Bourgeois, Hugues, Kiavue, Nicolas, Deluche, Elise, Ladoire, Sylvain, Campone, Mario, Pierga, Jean-Yves, Bidard, Francois-Clement
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007590/
https://www.ncbi.nlm.nih.gov/pubmed/33473163
http://dx.doi.org/10.1038/s41416-020-01227-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007590/
https://www.ncbi.nlm.nih.gov/pubmed/33473163
http://dx.doi.org/10.1038/s41416-020-01227-3

Ejemplares similares